Seminars in Arthritis and Rheumatism
Volume 40, Issue 5 , Pages 473-478 , April 2011

Estimation of the Prevalence of Rheumatic Diseases in Israel

  • Michael Yaron, MD

      Affiliations

    • Department of Rheumatology, Tel Aviv Sourasky Medical Center Tel Aviv, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    • Corresponding Author InformationAddress reprint requests to: Michael Yaron, MD, Department of Rheumatology, Tel Aviv Sourasky Medical Center, 6 Weizmann St., Tel Aviv, Israel 62439
  • ,
  • Dan Caspi, MD

      Affiliations

    • Department of Rheumatology, Tel Aviv Sourasky Medical Center Tel Aviv, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
  • ,
  • Ilana Kaufman, MD

      Affiliations

    • Department of Rheumatology, Tel Aviv Sourasky Medical Center Tel Aviv, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
  • ,
  • Mina Zemach, PhD

      Affiliations

    • Dahaf Research Institute, Tel Aviv-Jaffa, Israel
  • ,
  • Itamar Grotto, MD, PhD, MPH

      Affiliations

    • Ben-Gurion University of the Negev, Beer Sheva, Israel
  • ,
  • Roy Altman, MD

      Affiliations

    • Roy Altman–David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California

References 

  1. Yaron M, Yaron I, Zemach M, Caspi D. Prevalence and impact of rheumatic complaints in an urban population of Israel. Ann Rheum Dis. 2008;67(Suppl. Abst. 2):688
  2. Jaber L, Milo G, Halpern GJ, Krause I, Weinberger A. Prevalence of Behcet's disease in an Arab community in Israel. Ann Rheum Dis. 2002;61:365–366
  3. Adler E, Abramson JH, Elkan Z, Ben Hadar S. Rheumatoid arthritis in a Jerusalem population (1. Epidemiology of the diseases). Am J Epidemiol. 1967;85:365–377
  4. Muirden KD. Community oriented program for the control of rheumatic diseases: studies of rheumatic diseases in the developing world. Curr Opin Rheumatol. 2005;17:153–156
  5. Chopra A. COPCORD—An unrecognized fountainhead of community rheumatology in developing countries. J Rheumatol. 2004;31:2320–2321
  6. Darmawan J, Muirden KD. WHO-ILAR COPCORD perspectives past, present and future. J Rheumatol. 2003;30:2312–2314
  7. Bennet K, Cardiel MH, Ferraz MB, Riedemann P, Goldsmith CH, Tugwell P. Community screening for rheumatic disorder: characteristics of the COPCORD Core Questionnaire in Brazil (Chile and Mexico). J Rheumatol. 1997;24:160–168
  8. Wigley R, Manahan L, Muirden KD, Caragay R, Pinfold B, Couchman KG, et al. Rheumatic diseases in a Philippine village II: A WHO-ILAR-APLAR-COPCORD study, phase II and III. Rheumatol Int. 1991;11:157–161
  9. Darmawan J, Valkenburg HA, Muirden KD, Wigley RD. Epidemiology of rheumatic diseases in rural and urban populations in Indonesia (A WHO/ILAR COPCORD study, Stage 1, Phase 2). Ann Rheum Dis. 1992;51:525–528
  10. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. Criteria for the Classification and Diagnosis of the Rheumatic Diseases (Primer on the Rheumatic Diseases. Appendix 1). In:  Klippel JH,  Stone JH,  Crofford LJ, et al. editor. 13th ed.. New York (NY): Springer science & Business Media, LLC; 2008;p. 669–682
  11. Biundo JJ. Regional Rheumatic Syndromes (Primer on the Rheumatic Diseases). In:  Klippel JH,  Stone JH,  Crofford LJ, et al. editor. 13th ed.. New York (NY): Springer science & Business Media, LLC; 2008;p. 70;table 3D-2
  12. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States (Part I). Arthritis Rheum. 2008;58:15–25
  13. Yelin E, Callahan LF. The economic cost and social and psychological impact of musculoskeletal conditions. Arthritis Rheum. 1995;38:1351–1362

 This study was supported by a generous unrestricted gift from Amisragas, the American-Israel Gas Corporation.

PII: S0049-0172(10)00086-7

doi: 10.1016/j.semarthrit.2010.05.010

Seminars in Arthritis and Rheumatism
Volume 40, Issue 5 , Pages 473-478 , April 2011